Generation and characterization of neutralizing monoclonal antibodies against baculo-expressed HPV 16 VLPs

Human papillomavirus (HPV) is the well-known second most cause of cervical cancer in women worldwide. According to the WHO survey, 70% of the total cervical cancers are associated with types HPV 16 and 18. Presently used prophylactic vaccine for HPV contains mainly capsid protein of L1 virus like pa...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Vidyasagar, P., Sridevi, V. N., Rajan, S., Praveen, A., Srikanth, A., Abhinay, G., Siva Kumar, V., Verma, R. R., Rajendra, L.
Médium: Artigo
Jazyk:Inglês
Vydáno: Akadémiai Kiadó 2014
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3955832/
https://ncbi.nlm.nih.gov/pubmed/24678406
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1556/EuJMI.4.2014.1.5
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky